Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-09-26

Jing Xie

Role not yet determined Is this you? Add your title

2 pubs

  • Immune Checkpoint Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Esophageal Neoplasms
  • Esophagogastric Junction
  • Stomach Neoplasms
  • Pathologic Complete Response
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Perioperative Care

Biography and Research Information

OverviewAI-generated summary

Jing Xie's research centers on analyzing the efficacy and safety of medical procedures, with a recent focus on traction-assisted endoscopic submucosal dissection for superficial gastric neoplasms. This work is presented as a meta-analysis of randomized controlled trials, indicating a methodology that synthesizes existing research to draw broader conclusions. Xie has one publication to date, a 2026 meta-analysis. Xie collaborates with Rui Zhang at the University of Arkansas for Medical Sciences, with whom one shared publication exists. Xie is noted as recently active in research.

Metrics

  • Publications: 2

Selected Publications

  • Perioperative immunochemotherapy for resectable gastric or gastroesophageal junction cancer: a meta-analysis of efficacy and safety from randomized trials (2026)
    Frontiers in Immunology DOI OpenAlex
  • Efficacy and safety of traction-assisted endoscopic submucosal dissection for superficial gastric neoplasms: a meta-analysis of randomized controlled trials (2026)
    Frontiers in Oncology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

9 Collaborators 5 Institutions 3 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics